Pure Pharmaceuticals CORP - FORM 10-K - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - January 5, 2010

Attached files

file filename
10-K - ANNUAL REPORT FOR THE YEAR ENDED SEPTEMBER 30, 2009 - Pure Pharmaceuticals CORPform10k.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Pure Pharmaceuticals CORPexhibit32-2.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Pure Pharmaceuticals CORPexhibit31-2.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Pure Pharmaceuticals CORPexhibit31-1.htm

Exhibit 32.1

CERTIFICATION

The undersigned, Roger Gordon, Principal Executive Officer of Pure Pharmaceuticals Corporation (the "Company") hereby certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to his knowledge:

  (1)

the Annual Report on Form 10-K of the Company for the year ended September 30, 2009 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

     
  (2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: December 30, 2009

  /s/ Roger Gordon
  Roger Gordon
  Principal Executive Officer

___________________________

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Pure Pharmaceuticals CORP Reports